Overview

Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will be a randomized, double blind, placebo-controlled, parallel group study and will include subjects with ragweed-induced seasonal allergic rhinitis.
Phase:
N/A
Details
Lead Sponsor:
Creighton University
Collaborator:
Roche Pharma AG
Treatments:
Fluticasone
Montelukast